89bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	28.97	21.45	19.41	13.16	5.29	1.48
Research & Development	122.23	80.8	70.33	36.2	21.35	13.68
Operating Expenses	151.2	102.25	89.74	49.36	26.64	15.16
Operating Income	-151.2	-102.25	-89.74	-49.36	-26.64	-15.16
Interest Expense / Income	4.79	1.92	0.67	0	0	0
Other Expense / Income	-17.68	-2.16	-0.15	0.2	30.56	0.99
Pretax Income	-138.32	-102.01	-90.27	-49.56	-57.2	-16.15
Income Tax	3.87	0.02	-0.15	-0.06	0.22	0.03
Net Income	-142.19	-102.03	-90.12	-49.5	-57.42	-16.18
Shares Outstanding (Basic)	71	35	20	16	2	0
Shares Outstanding (Diluted)	71	35	20	16	2	0
Shares Change	104.48%	73.18%	24.93%	586.28%	428.25%	-
EPS (Basic)	-2.00	-2.93	-4.48	-3.08	-24.49	-36.45
EPS (Diluted)	-2.00	-2.93	-4.48	-3.08	-24.49	-36.45
Free Cash Flow	-129.19	-81.1	-76.84	-46.37	-25.6	-12.51
Free Cash Flow Per Share	-1.81	-2.33	-3.82	-2.88	-10.92	-28.19
EBITDA	-133.26	-99.85	-89.52	-49.5	-57.19	-16.14
Depreciation & Amortization	0.27	0.24	0.08	0.06	0.02	0.01
EBIT	-133.53	-100.09	-89.6	-49.56	-57.2	-16.15

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).